We are live on ! Find out more

974 hedge funds and large institutions have $21B invested in Labcorp in 2025 Q2 according to their latest regulatory filings, with 106 funds opening new positions, 339 increasing their positions, 363 reducing their positions, and 92 closing their positions.

New
Increased
Maintained
Reduced
Closed

32% more call options, than puts

Call options by funds: $79.4M | Put options by funds: $60.2M

16% more capital invested

Capital invested by funds: $18.1B → $21B (+$2.89B)

15% more first-time investments, than exits

New positions opened: 106 | Existing positions closed: 92

2.61% more ownership

Funds ownership: 93.09%95.7% (+2.6%)

0% more funds holding

Funds holding: 973974 (+1)

0% more funds holding in top 10

Funds holding in top 10: 1313 (0)

7% less repeat investments, than reductions

Existing positions increased: 339 | Existing positions reduced: 363

Holders
974
Holders Change
+1
Holders Change %
+0.1%
% of All Funds
12.82%
Holding in Top 10
13
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.17%
New
106
Increased
339
Reduced
363
Closed
92
Calls
$79.4M
Puts
$60.2M
Net Calls
+$19.2M
Net Calls Change
+$23.7M
Name Holding Trade Value Shares
Change
Change in
Stake
Lord, Abbett & Co
26
Lord, Abbett & Co
New Jersey
$194M -$10.7M -43,890 -6%
Bank of America
27
Bank of America
North Carolina
$183M -$28.5M -116,860 -14%
Legal & General Group
28
Legal & General Group
United Kingdom
$177M +$5.02M +20,621 +3%
Charles Schwab
29
Charles Schwab
California
$177M +$9.59M +39,380 +6%
BMO
30
Beck Mack & Oliver
New York
$161M -$3.16M -12,983 -2%
Massachusetts Financial Services
31
Massachusetts Financial Services
Massachusetts
$158M +$6.98M +28,653 +5%
MAM
32
Madison Asset Management
Wisconsin
$150M +$3.44M +14,124 +3%
Thrivent Financial for Lutherans
33
Thrivent Financial for Lutherans
Minnesota
$136M +$25.7M +105,453 +26%
Natixis Advisors
34
Natixis Advisors
Massachusetts
$131M +$36.1M +148,122 +42%
UBS Group
35
UBS Group
Switzerland
$131M +$13.6M +55,790 +13%
Alyeska Investment Group
36
Alyeska Investment Group
Illinois
$118M -$15.9M -65,406 -13%
Goldman Sachs
37
Goldman Sachs
New York
$105M +$11.5M +47,035 +13%
Hotchkis & Wiley Capital Management
38
Hotchkis & Wiley Capital Management
California
$101M -$1.26M -5,188 -1%
AI
39
Ariel Investments
Illinois
$95.9M -$698K -2,865 -0.8%
Marshall Wace
40
Marshall Wace
United Kingdom
$91.4M +$67.9M +278,855 +403%
EARNEST Partners
41
EARNEST Partners
Georgia
$87M +$396K +1,626 +0.5%
Wells Fargo
42
Wells Fargo
California
$83.7M -$2.01M -8,273 -3%
Fidelity International
43
Fidelity International
Bermuda
$82.4M -$16.6M -68,308 -18%
Deutsche Bank
44
Deutsche Bank
Germany
$81.3M -$6.38M -26,207 -8%
Barclays
45
Barclays
United Kingdom
$78.2M -$20.6M -84,785 -22%
California Public Employees Retirement System
46
California Public Employees Retirement System
California
$75.4M -$13.9M -57,050 -17%
Envestnet Asset Management
47
Envestnet Asset Management
Illinois
$72.7M +$809K +3,322 +1%
GIM
48
Glenmede Investment Management
Pennsylvania
$72.2M +$66.9M +274,912 New
Amundi
49
Amundi
France
$71.3M -$195M -799,075 -74%
CI
50
Cambiar Investors
Colorado
$66.5M -$2.36M -9,708 -4%

LH Hedge Fund Activity: Q2 2025 in Review

974 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in Labcorp (LH) for Q2 2025, worth a combined $21B — up 16% from $18.1B a quarter earlier.

Buyers outnumbered sellers: 106 funds opened new LH positions and 92 closed out — a net gain of 14 holders — while 339 added to existing stakes and 363 trimmed.

The largest buyer was Victory Capital Management, adding an estimated $521M. The largest seller was Amundi, cutting an estimated $195M.

  • 974 institutional investors held Labcorp (LH) as of Q2 2025, up from 973 in Q1 2025.
  • Funds reported $21B of Labcorp stock for Q2 2025, up 16% quarter-over-quarter.
  • 106 funds opened new Labcorp positions in Q2 2025 and 92 closed out, a net change of +14 holders.
  • The largest Labcorp buyer in Q2 2025 was Victory Capital Management, an estimated $521M added.
  • The largest Labcorp seller in Q2 2025 was Amundi, an estimated $195M sold.

Based on aggregated 13F filings for Q2 2025.